Table 2.
Comparison of demographics, clinical characteristics, laboratory data, and inflammatory cytokines between the N and L groups in nonelderly participants.
| Nonelderly | N (n = 127) | L (n = 18) | p |
|---|---|---|---|
| Male/female | 45/82 | 4/14 | 0.202 |
| Age (yrs) | 55.1 ± 7.2 | 58.1 ± 5.0 | 0.004 |
| BMI (kg/m2) | 24.0 ± 3.4 | 19.5 ± 2.0 | <0.001 |
| BFP (%) | 29.9 ± 7.6 | 25.9 ± 5.7 | 0.017 |
| Gait speed (m/s) | 2.67 ± 0.42 | 2.60 ± 0.40 | 0.502 |
| Smoking history (y/n) | 20/107 | 2/16 | 1.000 |
| Hypertension (y/n) | 22/105 | 2/16 | 0.394 |
| Diabetes (y/n) | 8/119 | 1/17 | 0.690 |
| Hyperlipidemia (y/n) | 31/96 | 2/16 | 0.170 |
| HbA1c (%) | 5.6 ± 0.4 | 5.5 ± 0.5 | 0.276 |
| Alb (g/dl) | 4.32 ± 0.24 | 4.27 ± 0.32 | 0.472 |
| AST (U/I) | 21.2 ± 6.3 | 22.5 ± 11.3 | 0.833 |
| ALT (U/I) | 22.2 ± 13.2 | 19.8 ± 12.0 | 0.248 |
| T-cho (mg/dl) | 217.4 ± 36.0 | 212.8 ± 27.0 | 0.869 |
| BUN (mg/dl) | 13.8 ± 3.3 | 14.6 ± 3.5 | 0.393 |
| Cre (mg/dl) | 0.71 ± 0.13 | 0.66 ± 0.12 | 0.129 |
| CRP (mg/dl) | 0.06 ± 0.11 | 0.03 ± 0.05 | 0.046 |
| TNF-alpha (pg/ml) | 11.7 ± 11.0 | 10.2 ± 8.2 | 0.776 |
| IL-6 (pg/ml) | 10.2 ± 39.9 | 5.8 ± 4.3 | 0.823 |
| MCP-1 (pg/ml) | 61.3 ± 53.7 | 72.7 ± 60.7 | 0.328 |
BMI: body mass index; BFP: body fat percentage; N: N group (ASMI ≥ 7.0 kg/m2 and 5.7 kg/m2 in men and women, respectively); L: L group (ASMI < 7.0 kg/m2 and 5.7 kg/m2 in men and women, respectively); ASMI: appendicular skeletal muscle mass; appendicular soft lean mass/(height)2.